Health Decisions

Description

Health Decisions is pleased to provide a rich selection of resources to current and potential customers in the biopharma and medical device industries. We provide press releases about accomplishments on behalf of our sponsors, innovations in clinical development, awards received, media recognition and other noteworthy events. Our publications include articles and white papers on important issues and trends in clinical development. We provide glimpses of our work on specific projects through case studies and concise success stories that are respectful of client confidentiality.

Health Decisions provides all the services of a traditional CRO and more – that is why we are a CRO+. We meet the development needs of biopharma and medical device companies worldwide. Fueled by insight and agility, services include managing individual phase I-IV trials of drugs and biologics; managing 510(k), PMA and CE Mark trials of medical devices; consulting on projects involving trial planning, design and biostatistics; and serving as a full-service virtual development arm – planning, managing and executing entire programs.

Health Decisions provides sponsors with Global Agility, flexible global reach enabling them to conduct a global study in the most favorable locations without incurring overhead costs from nonparticipating regions and sites. We provide Global Agility through a combination of data-driven central management from the US with the regional experience, expertise and insight of carefully selected resources in each country or region.

The Health Decisions GI team has strong relationships with sites and investigators, including KOLs, and is proficient in the use of Health Decisions’ advanced systems and processes to keep sponsors in control and ensure that studies meet their goals. Health Decisions’ study management tools enable our proactive study teams to manage sites effectively, keep enrollment on track and work closely with sites to maximize subject retention.

Health Decisions has conducted a variety of nephrology studies, including studies of chronic kidney disease (CKD) stage 5 CKD and renal cell carcinoma. We understand the challenges of working with dialysis subjects and in the dialysis setting and have extensive experience partnering with major hemodialysis SMOs, facilitating site selection and ensuring consistency in site training. We conduct nephrology studies with great efficiency whether they involve a few sites and subjects or dozens of sites and large populations. View additional information on Health Decisions’ nephrology expertise.

Fact sheet

Company contacts

Products & services

Similar companies nearby